Tan Bo
biomedicine
3Sbio
China
Biography
Mr. TAN Bo (èšæ“˜) was appointed as a Director of our Company on May 29, 2013 and was redesignated as an executive Director of our Company on November 27, 2014. Mr. Tan is also our chief financial officer and executive vice president. He is responsible for overseeing the financial activities and the daily operation of the business development of our Group. Mr. Tan joined Shenyang Sunshine as the chief financial officer and vice president in February 2009. Mr. Tan has extensive experience within the financial and pharmaceutical industries, and has worked in private equity, equity research and commercial sectors. He served as executive director and a member of the investment committee of Bohai Industrial Investment Fund Management Company (æ¸¤æµ·ç”¢æ¥æŠ•è³‡åŸºé‡‘ç®¡ç†å…¬å¸) (“Bohai Fund”), a private equity fund in China, from April 2007 to September 2008. Before that, he served as a vice president in the equity research division of Lehman Brothers Asia Limited from March 2006 to March 2007. He worked as a senior analyst at Macquarie Securities Asia in Hong Kong from October 2004 to February 2006.
Research Interest
pharma